{
 "PrintNo":"S4150","Session":2025,"Chamber":"SENATE","BillType":"Senate","Published":"2025-02-03T10:29:40.980047Z",
 "Status":"IN_SENATE_COMM","Committee":"Alcoholism And Substance Use Disorders",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2025-02-03","Committee":"Alcoholism And Substance Use Disorders"}],
 "Actions":[{"Text":"REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS","Date":"2025-02-03","Chamber":"SENATE"}],
 "Sponsors":[
  {"ID":1233,"Name":"Pete Harckham","Short":"HARCKHAM"},{"ID":384,"Name":"Joseph P. Addabbo Jr.","Short":"ADDABBO"},
  {"ID":1522,"Name":"Jake Ashby","Short":"ASHBY"},{"ID":1501,"Name":"Jeremy Cooney","Short":"COONEY"},
  {"ID":1571,"Name":"Patricia Fahy","Short":"FAHY"},{"ID":427,"Name":"Patrick M. Gallivan","Short":"GALLIVAN"},
  {"ID":1499,"Name":"Peter Oberacker","Short":"OBERACKER"},{"ID":1551,"Name":"Christopher Ryan","Short":"RYAN C"},
  {"ID":1142,"Name":"Luis R. Sepúlveda","Short":"SEPULVEDA"},{"ID":1232,"Name":"James Skoufis","Short":"SKOUFIS"}
 ],
 "Title":"Relates to the availability of opioid reversal agents",
 "Summary":"Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.",
 "LawSection":"Mental Hygiene Law","LawCode":"Amd §19.09, Ment Hyg L; amd §3309, Pub Health L",
 "ActClause":"AN ACT to amend the mental hygiene law and the public health law, in relation to the availability of opioid reversal agents",
 "SameAsPrintNo":"A265-2025","PreviousVersions":["S8991-2023"]
}